GlassScriptPhysician profile
David K Padgett
NPI 1699730374
$605.08
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $63.15 · 2021: $40.82 · 2022: $56.17.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $146.15 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $132.25 | 2019 | |
| Daiichi Sankyo INC. | $80.81 | 2019 | |
| Grt US Holding, INC. | $56.17 | 2022 | |
| Bioventus LLC | $34.44 | 2019-2021 | |
| Merz North America, INC. | $32.75 | 2019 | |
| Sanofi-Aventis U.S. LLC | $27.37 | 2019-2020 | |
| Electronic Waveform Lab, INC. | $23.85 | 2020 | |
| Nalu Medical, INC. | $20.30 | 2021 | |
| Amgen INC. | $19.18 | 2019 | |
| Collegium Pharmaceutical, INC. | $18.70 | 2019 | |
| Merck Sharp & Dohme LLC | $13.11 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Padgett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.